1636: The Efficacy and Safety of Tadalafil Administered Once a Day for Lower Urinary Tract Symptoms (LUTS) in Men with Benign Prostatic Hyperplasia (BPH)
Abstract
You have accessJournal of UrologyModerated Poster, Wednesday, May 24, 2006, 1:00 - 3:00 pm1 Apr 20061636: The Efficacy and Safety of Tadalafil Administered Once a Day for Lower Urinary Tract Symptoms (LUTS) in Men with Benign Prostatic Hyperplasia (BPH) Claus G. Roehrbom, Kevin T. McVary, Jed C. Kaminetsky, Stephen M. Auerbach, Barton Wachs, Jay M. Young, Anne Esler, Gregory D. Sides, and Bela S. Denes Claus G. RoehrbomClaus G. Roehrbom More articles by this author , Kevin T. McVaryKevin T. McVary More articles by this author , Jed C. KaminetskyJed C. Kaminetsky More articles by this author , Stephen M. AuerbachStephen M. Auerbach More articles by this author , Barton WachsBarton Wachs More articles by this author , Jay M. YoungJay M. Young More articles by this author , Anne EslerAnne Esler More articles by this author , Gregory D. SidesGregory D. Sides More articles by this author , and Bela S. DenesBela S. Denes More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)33828-XAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "1636: The Efficacy and Safety of Tadalafil Administered Once a Day for Lower Urinary Tract Symptoms (LUTS) in Men with Benign Prostatic Hyperplasia (BPH)." The Journal of Urology, 175(4S), p. 527 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 175Issue 4SApril 2006Page: 527 Advertisement Copyright & Permissions© 2016…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.